Overview
Odiparcil QT Definitive Study
Status:
Terminated
Terminated
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is being completed to demonstrate the lack of effect of repeat dosing with Odiparcil on the QTc interval.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
GlaxoSmithKline
Criteria
Inclusion:- Healthy volunteers
Exclusion:
- Cardiac abnormalities
- Hepatic or renal insufficiency
- Anti-coagulant medications
- Bleeding history